insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,44 US$
arrow_downward
-3,30%(-0,15) 1D
18 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,55 US$
High
4,60 US$
Low
4,41 US$
Mkt. cap
61,82 მლნ.
Avg. vol.
7,41 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,41 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Open
4,55 US$
High
4,60 US$
Low
4,41 US$
Mkt. cap
61,82 მლნ.
Avg. vol.
7,41 ათ.
Volume
0,00
52-wk high
8,31 US$
52-wk low
4,41 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
BigGo Finance
·
29 წუთის წინ
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
Business Insider
·
44 წუთის წინ
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
Yahoo Finance
·
42 წუთის წინ
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com